UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Correlation between Immunologic Responses to a Recombinant Glycoprotein 120 Vaccine and Incidence of HIV-1 Infection in a Phase 3 HIV-1 Preventive Vaccine Trial

The Journal of infectious diseases, 2005-03, Vol.191 (5), p.666-677

2005

Volltextzugriff (PDF)

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

The New England journal of medicine, 2009-12, Vol.361 (23), p.2209-2220

2009

Volltextzugriff (PDF)

Dengue vaccines regulatory pathways: a report on two meetings with regulators of developing countries

PLoS medicine, 2011-02, Vol.8 (2), p.e1000418

2011

Volltextzugriff (PDF)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

AIDS research and human retroviruses, 2015-11, Vol.31 (11), p.1178-1186

2015

Volltextzugriff (PDF)

Challenges and successes for the grantees and the Technical Advisory Group of WHO’s influenza vaccine technology transfer initiative

Vaccine, 2016-10, Vol.34 (45), p.5420-5424

2016

Volltextzugriff (PDF)

HIV-1 Virologic and Immunologic Progression and Initiation of Antiretroviral Therapy among HIV-1–Infected Subjects in a Trial of the Efficacy of Recombinant Glycoprotein 120 Vaccine

The Journal of infectious diseases, 2005-09, Vol.192 (6), p.974-983

2005

Volltextzugriff (PDF)

Deadly AIDS policy failure by the highest levels of the US government: A personal look back 30 years later for lessons to respond better to future epidemics

Journal of public health policy, 2012-08, Vol.33 (3), p.290-300

Francis, Donald P

2012

Volltextzugriff (PDF)

Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1

Journal of acquired immune deficiency syndromes (1999), 2004-09, Vol.37 (1), p.1160-1165

2004

Volltextzugriff (PDF)

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

AIDS research and human retroviruses, 2017-05, Vol.33 (5), p.410-423

2017

Volltextzugriff (PDF)

Protecting the public's health: remove the political constraints that hamper the Centers for Disease Control and Prevention

AIDS (London), 2012-06, Vol.26 (9), p.1175-1176

FRANCIS, Donald P

2012

Volltextzugriff (PDF)

Safe landing for global polio eradication: A perspective

Vaccine, 2011-11, Vol.29 (48), p.8827-8834

2011

Volltextzugriff (PDF)

Global vaccine supply. The increasing role of manufacturers from middle income countries

Vaccine, 2014-09, Vol.32 (41), p.5259-5265

2014

Volltextzugriff (PDF)

Successes and failures: Worldwide vaccine development and application

Biologicals, 2010-09, Vol.38 (5), p.523-528

Francis, Donald P.

2010

Volltextzugriff (PDF)

WHO influenza vaccine technology transfer initiative: Role and activities of the Technical Advisory Group

Vaccine, 2011-07, Vol.29 (S1), p.A45-A47

2011

Volltextzugriff (PDF)

The Need for a Global HIV Vaccine Enterprise

Science (American Association for the Advancement of Science), 2003-06, Vol.300 (5628), p.2036-2039

2003

Volltextzugriff (PDF)

Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials

AIDS (London), 2003-01, Vol.17 (2), p.147-156

2003

Volltextzugriff (PDF)

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

The New England journal of medicine, 1986-07, Vol.315 (4), p.209-214

1986

Volltextzugriff (PDF)

Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand

AIDS (London), 2004-01, Vol.18 (2), p.311-316

2004

Volltextzugriff (PDF)

WHO technology transfer activities for influenza vaccines

Virology & mycology infectious diseases, 2016, Vol.5 (3)

Francis, Donald P

2016

Volltextzugriff (PDF)

Genetic and Immunologic Characterization of Viruses Infecting MN-rgp120-Vaccinated Volunteers

The Journal of infectious diseases, 1997-08, Vol.176 (2), p.384-397

1997

Volltextzugriff (PDF)

Commentary: Deadly AIDS policy failure by the highest levels of the US government: A personal look back 30 years later for lessons to respond better to future epidemics

Journal of public health policy, 2012-08, Vol.33 (3), p.290-300

Francis, Donald P.

2012

Volltextzugriff (PDF)

Immunization with Envelope MN rgp120 Vaccine in Human Immunodeficiency Virus-Infected Pregnant Women

The Journal of infectious diseases, 1999-10, Vol.180 (4), p.1080-1088

1999

Volltextzugriff (PDF)

Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling

Journal of acquired immune deficiency syndromes (1988), 1993-09, Vol.6 (9), p.1043-1048

1993

Volltextzugriff (PDF)

1 – 25 von 629

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(544)
Mit Volltextzugriff
(486)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Correlation between Immunologic Responses to a Recombinant Glycoprotein 120 Vaccine and Incidence of HIV-1 Infection in a Phase 3 HIV-1 Preventive Vaccine Trial

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

Dengue vaccines regulatory pathways: a report on two meetings with regulators of developing countries

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

Challenges and successes for the grantees and the Technical Advisory Group of WHO’s influenza vaccine technology transfer initiative

HIV-1 Virologic and Immunologic Progression and Initiation of Antiretroviral Therapy among HIV-1–Infected Subjects in a Trial of the Efficacy of Recombinant Glycoprotein 120 Vaccine

Deadly AIDS policy failure by the highest levels of the US government: A personal look back 30 years later for lessons to respond better to future epidemics

Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

Protecting the public's health: remove the political constraints that hamper the Centers for Disease Control and Prevention

Safe landing for global polio eradication: A perspective

Global vaccine supply. The increasing role of manufacturers from middle income countries

Successes and failures: Worldwide vaccine development and application

WHO influenza vaccine technology transfer initiative: Role and activities of the Technical Advisory Group

The Need for a Global HIV Vaccine Enterprise

Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX®B/E HIV vaccine trial, Bangkok, Thailand

WHO technology transfer activities for influenza vaccines

Genetic and Immunologic Characterization of Viruses Infecting MN-rgp120-Vaccinated Volunteers

Commentary: Deadly AIDS policy failure by the highest levels of the US government: A personal look back 30 years later for lessons to respond better to future epidemics

Immunization with Envelope MN rgp120 Vaccine in Human Immunodeficiency Virus-Infected Pregnant Women

Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling

Suchergebnisse filtern